Wird geladen...
A systematic review and network meta-analysis of post-imatinib therapy in advanced gastrointestinal stromal tumour
BACKGROUND: The standard first-line systemic therapy for advanced gastrointestinal stromal tumour (gist) is imatinib. However, most gists develop imatinib resistance, highlighting the need for new agents in the imatinib-refractory setting. Currently, no randomized studies have directly compared the...
Gespeichert in:
| Veröffentlicht in: | Curr Oncol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Multimed Inc.
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5736493/ https://ncbi.nlm.nih.gov/pubmed/29270063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3463 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|